Medical Properties Trust shows a credible stabilization story as rent ramps and restructurings improve, but heavy leverage and tenant risk keep the stock in Hold territory.
Medical Properties Trust (MPT) is a high-risk hospital REIT with a credible stabilization story, but its leverage and tenant exposure limit the margin of safety. The company reported Q1 2026 revenue of $252.1 million, up 12.6% year over year, and net income attributable to common stockholders of $32.8 million. Yet adjusted net debt stood at $8.7 billion, equal to 9.3x transaction-adjusted annualized EBITDAre.
The bullish case rests on rent recovery and asset repositioning. MPT expects annualized cash rent to exceed $1 billion by the end of 2026, while the six former Prospect hospitals leased to NOR Health Systems are scheduled to reach $45 million of annual rent in December 2026. The company also completed a Vibra restructuring, secured a new 20-year master lease, and received an $18 million one-time rent payment.
The investment tradeoff is straightforward. MPT's forward P/E of 6.7x and $4.18 share price leave room for a recovery, but full-year 2025 still produced a net loss of $277.0 million and the balance sheet carries $9.7 billion of debt. For a moderate-risk investor with a medium-term horizon, the proper stance is Hold rather than Buy: the recovery has substance, but refinancing execution must keep pace with rent stabilization.
Medical Properties Trust is a net-lease REIT focused on hospital real estate. It buys hospitals and leases them to healthcare operators, often using sale-leaseback transactions that provide operators with capital while giving MPT contractual rent and financing income.
As of March 31, 2026, MPT reported 388 properties, about 39,000 licensed beds, operations across 9 countries, and 51 tenant relationships. The company lists approximately $14.8 billion of total assets and a $2.8 billion market capitalization. The latest core valuation data lists revenue of $1.1 billion and EBITDA of $950.0 million.
MPT's strategy has shifted from rapid portfolio expansion toward repair and selective growth. The 2025 priorities included exiting Prospect, restructuring Vibra, managing debt maturities, and ramping rents from re-tenanted Steward properties. That shift matters because the quality of rent collection now matters more than raw property count.
General acute care hospitals are MPT's core segment. The portfolio includes 162 general acute properties, representing 58.8% of total assets and 62.0% of Q1 2026 revenue. General acute operators produced more than $130 million of year-over-year EBITDARM improvement in the fourth quarter of 2025.
Behavioral health accounted for 68 properties, 16.3% of assets, and 22.0% of Q1 2026 revenue. The segment was slightly weaker year over year in the fourth quarter of 2025. U.S. labor costs pressured results, while U.K. operations faced volume and NHS budget constraints. LifePoint Behavioral is implementing program changes intended to control labor costs and improve its revenue mix.
Post-acute care represented 128 properties, 11.3% of assets, and 15.2% of Q1 2026 revenue. The segment delivered a $50 million year-over-year EBITDARM increase for the second consecutive quarter. Ernest Health reported a 15% improvement, Vibra reported a 28% improvement, and Median reported an 8% increase in the fourth-quarter discussion.
The portfolio is becoming more balanced operationally, but not uniformly safer. General acute and post-acute results improved, while behavioral health still carries staffing and public-funding pressure. That mix gives MPT several recovery levers, though hospital operator credit remains the central risk.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
MPT's flagship offering is its hospital sale-leaseback and capital-solutions platform. Instead of selling a standardized product, MPT provides property capital tailored to hospitals, long-term care facilities, and behavioral health operators. The economic output is a portfolio of long-duration leases, financing leases, and mortgage loans.
The model works best when a mission-critical property supports a financially sound operator. MPT's absolute net master leases place property-level expenses with tenants, while hospital operators receive capital for operations and facility investment. The model worked through the Vibra restructuring, which produced a new 20-year master lease and an $18 million payment for past obligations.
The flagship platform also creates recovery opportunities when a tenant fails. MPT signed a 15-year lease with NOR Health Systems for six California properties formerly leased to Prospect. NOR is scheduled to begin partial rent in June 2026 and reach $45 million of annual cash rent in December 2026. This is a practical demonstration of the platform's re-tenanting value, although the rent ramp remains important to the broader recovery.
MPT's advantage is specialized underwriting rather than proprietary technology. The company evaluates hospital properties using physical quality, competition, demographics, market conditions, and operator finances. It also combines real estate ownership with lending capability, allowing it to provide debt capital as well as acquire property.
Mission-critical hospitals create a useful real estate moat. MPT's supplemental materials show that 85.9% of base rent and interest matures thereafter rather than in the near term, and the largest individual facility represents less than 2% of total assets. Hospitals are expensive and disruptive to replace, which supports long lease structures when the operator remains viable.
The company is also using operational modernization as a form of innovation. HSA plans to implement the MEDITECH electronic medical record system in Q2 2026, with management linking the system to revenue-cycle improvements and cost savings. Swiss Medical Network's clinical collaboration with the Mayo Clinic adds another example of tenant-level capability building that can strengthen asset quality over time.
MPT does not operate hospitals directly. Its operating chain runs from property acquisition and financing to lease execution, tenant performance, rent collection, and asset recycling. That structure keeps corporate operations relatively focused, but it makes MPT dependent on the clinical and financial execution of its tenants.
The international portfolio represents 50% of MPT's investments. Median in Germany recorded its strongest quarter since entering the portfolio, with quarterly EBITDARM up more than 20% year over year and occupancy at 90%. Improving reimbursement and orthopedic demand supported that result.
In the United States, Ernest Health delivered double-digit EBITDARM growth, supported by inpatient rehabilitation facilities and new inpatient rehab units inside long-term acute care facilities. Ernest also refinanced its term loan and revolver in the fourth quarter of 2025, extending maturities to 2030 and reducing its interest rate.
MPT sold two facilities in Q1 2026 for approximately $31 million in aggregate proceeds and acquired a European post-acute facility for €23 million. In the fourth quarter of 2025, it sold six smaller underperforming properties and invested roughly $60 million in two post-acute rehabilitation facilities. This recycling program is sensible when sales reduce weaker exposure and acquisitions support established tenants.
MPT operates in a specialized segment of healthcare real estate: hospital sale-leasebacks, hospital property financing, and re-tenanting of complex healthcare assets. The company's materials describe the acute and post-acute hospital real estate market as an attractive source of growth opportunities in both the United States and Europe.
The market is shaped by three concrete forces. Healthcare operators need capital for facility upgrades and working operations, hospital properties are costly to replace, and reimbursement determines whether operators can cover rent. MPT's Q4 2025 portfolio EBITDARM coverage of 2.6x shows meaningful aggregate support, but behavioral health pressure and prior tenant failures show why property quality alone cannot settle the investment case.
Healthcare REIT activity is also shifting toward outpatient and lower-acuity assets, which are generally less exposed to inpatient operator stress. MPT remains concentrated in hospitals, with general acute properties representing 58.8% of assets. That focus gives MPT a distinctive niche, but it also leaves the company more exposed to tenant credit and reimbursement cycles than medical-office peers.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
MPT's customers are healthcare operators that control hospitals, rehabilitation facilities, and behavioral health properties. Named relationships include Circle Health, Priory Group, Healthcare Systems of America, Swiss Medical Network, Lifepoint Behavioral Health, Ernest Health, Vibra, Surgery Partners, and Median.
The customer base spans nine countries and includes U.S. and international operators. MPT's international exposure provides geographic diversification, while its 51 tenant relationships reduce reliance on a single facility. The business remains exposed to operator concentration at the relationship level, however, because one struggling healthcare system can affect rent collection across multiple properties.
Customer quality is improving in selected relationships. Vibra refinanced its debt and entered a new 20-year master lease. NOR is taking over six California hospitals from Prospect, and HSA's monthly rent had reached 75% of fully stabilized rent by March 2026. These developments support the stabilization thesis, but they also show that customer transitions are active components of MPT's earnings model.
MPT's relevant public peers include Omega Healthcare Investors (OHI), Sabra Health Care REIT (SBRA), CareTrust REIT (CTRE), Healthpeak Properties (DOC), Healthcare Realty Trust (HR), Global Medical REIT (GMRE), and Community Healthcare Trust (CHCT). The comparison is imperfect because these companies have different exposure to skilled nursing, senior housing, medical office, life science, outpatient, and hospital assets.
MPT stands apart through its hospital specialization, international scale, and ability to combine property ownership with operator financing. Its portfolio of 162 general acute properties gives it more direct exposure to large, complex hospitals than outpatient-focused peers such as HR and DOC.
That specialization cuts both ways. Hospital properties can be mission-critical and difficult to replace, but they are also tied to staffing, reimbursement, patient volumes, and operator balance sheets. MPT's restructuring work with Prospect and Vibra illustrates a risk profile that is more operationally involved than the typical medical-office landlord.
Interest rates are the largest macro variable for MPT because the company carries $9.7 billion of debt against $425.0 million of cash. The nearest listed maturity is a €500 million unsecured notes issue due in October 2026, followed by a bank revolver and $200 million term loan due in June 2027 and $1.4 billion of unsecured notes due in October 2027.
MPT has several refinancing and deleveraging tools. Management cited secured debt, asset sales, and additional capital-market transactions. It also reported favorable financing precedents, including $2.5 billion of secured notes issued the prior year and a 10-year secured financing for its German rehabilitation portfolio at a coupon near 5%.
Policy exposure is equally important. Priory's U.K. behavioral health operations faced NHS budget constraints, while MPT identified Medicaid funding changes introduced by the OBBBA as a risk to tenant operations. In Germany, improving reimbursement supported Median's results, showing how policy can function as both a headwind and a tailwind across the portfolio.
Currency exposure also follows from the international portfolio and euro-denominated debt. MPT's geographic diversification reduces dependence on any one healthcare system, but it adds political, reimbursement, and foreign-exchange variables to an already leveraged structure.
Adjusted net debt was $8.7 billion, or 9.3x transaction-adjusted annualized EBITDAre, leaving little margin for error as MPT works through its refinancing plan.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Q1 2026 revenue rose 12.6% year over year to $252.1 million, but full-year 2025 still showed a $277.0 million net loss.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →MPT expects annualized cash rent to top $1 billion by the end of 2026, helped by NOR Health Systems ramping to $45 million of annual rent in December 2026.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →At 6.7x forward earnings and a $4.18 share price, MPT screens as inexpensive if the rent recovery holds and debt execution stays on track.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The report lands on a Hold because the recovery is real, but the stock still needs rent stabilization and balance-sheet repair to justify a stronger call.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →MPT has moved beyond the worst phase of its tenant-restructuring story, but it has not completed the balance-sheet repair that would make the stock a straightforward value purchase. Q1 2026 revenue growth, stronger general acute and post-acute coverage, Vibra's new master lease, and the NOR rent ramp are meaningful improvements.
The counterweight is just as concrete. Full-year 2025 produced a $277.0 million net loss, adjusted net debt was $8.7 billion, and total debt was $9.7 billion. The October 2026 maturity and the 2027 maturities make financing execution a central part of the equity case, not a footnote.
The balanced conclusion is Hold. MPT offers recovery upside from $4.18, but moderate-risk investors should demand evidence of sustained cash-rent growth and debt reduction before treating the shares as a core healthcare REIT holding. The report's fair value estimate of $5.20 recognizes the improving operations without ignoring the balance-sheet burden.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
Medical Properties Trust, Inc. (MPT) beat EPS and revenue, yet shares fell as investors looked past the headline to debt, rent collection, and tenant recovery. This deep-dive examines coverage ratios, refinancing progress, normalized FFO, and the path to more durable cash flow.
Medical Properties Trust, Inc. (MPT) falls 11.4% after reporting earnings beats, as investors react to the latest results and outlook.
Sabesp combines a long-dated regulated concession with strong cash generation and a large sanitation investment program. The stock looks inexpensive on earnings and cash flow, but leverage and execution risk keep the path to upside disciplined.